BIOMAT Database Logo BIOMAT Database Logo

[Analysis of binding capacities between HLA class II molecules and synthetic peptides HA307-319]. 1993

K Ikeda, and M Katagiri
2nd Department of Pathology, Asahikawa Medical College, Japan.

MHC class II molecules control immune responses for T cell recognition of peptide antigens. In this study, we have examined the lymphocyte proliferative response (LPR) for HA307-319, a synthetic peptide, derived from hemagglutinin of a human influenza virus A strain, and the binding capacities of several DR and DQ molecules, which are frequently expressed in Japanese, with HA307-319. The high response of lymphocytes to HA307-319 was observed in DR1-positive subjects, and DR1 molecules had higher binding capacitise than DR2 and DR9 with the peptide. Also, three types of DQ molecules could bind weakly with HA307-319.

UI MeSH Term Description Entries
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D006389 Hemagglutinins, Viral Specific hemagglutinin subtypes encoded by VIRUSES. Viral Hemagglutinin,Viral Hemagglutinins,Hemagglutinin, Viral
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein

Related Publications

K Ikeda, and M Katagiri
Direct binding of influenza peptides to class I HLA molecules.
February 1989, Nature,
K Ikeda, and M Katagiri
Promiscuous binding of proinsulin peptides to Type 1 diabetes-permissive and -protective HLA class II molecules.
April 2003, Diabetologia,
K Ikeda, and M Katagiri
Evidence of widespread binding of HLA class I molecules to peptides.
September 1990, The Journal of experimental medicine,
K Ikeda, and M Katagiri
Identification of MHC class II binding peptides: microarray and soluble MHC class II molecules.
January 2009, Methods in molecular biology (Clifton, N.J.),
K Ikeda, and M Katagiri
Recognition of HLA class II molecules by antipeptide antibodies elicited by synthetic peptides selected from regions of HLA-DP antigens.
January 1987, Zeitschrift fur Naturforschung. C, Journal of biosciences,
K Ikeda, and M Katagiri
Anchor residue motifs of HLA class-I-binding peptides analyzed by the direct binding of synthetic peptides to HLA class I alpha chains.
November 1993, Human immunology,
K Ikeda, and M Katagiri
HLA class I binding of synthetic nonamer peptides carrying major anchor residue motifs of HLA-B27 (B*2705)-binding peptides.
January 1993, Immunogenetics,
K Ikeda, and M Katagiri
In silico tools for predicting peptides binding to HLA-class II molecules: more confusion than conclusion.
January 2008, Journal of proteome research,
K Ikeda, and M Katagiri
MHC class II binding of peptides derived from HLA-DR 1.
April 1992, Journal of immunology (Baltimore, Md. : 1950),
K Ikeda, and M Katagiri
Specific binding of leukemia oncogene fusion protein peptides to HLA class I molecules.
May 1995, Blood,
Copied contents to your clipboard!